Proteomics

Dataset Information

0

Proteomic Time-Course Investigation into the Effects of Exposure of Mycobacterium smegmatis to Sub-Lethal Dose of Rifampicin


ABSTRACT: Drug susceptible Mycobacterium smegmatis (Mc2-155) was exposed to a sub-MIC concentration of antimycobacterial drug Rifampicin (treated) or DMSO (control). Cells were harvested at 30, 255 and 300 minutes post-exposure and the proteome at each time analysed using LC-MS/MS on a Thermo Q-Exactive.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Mycobacterium Smegmatis Str. Mc2 155 (ncbitaxon:246196)

SUBMITTER: Jonathan M Blackburn  

PROVIDER: MSV000083589 | MassIVE | Mon Mar 18 06:09:00 GMT 2019

SECONDARY ACCESSION(S): PXD004197

REPOSITORIES: MassIVE

altmetric image

Publications

A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations.

Giddey Alexander D AD   de Kock Elise E   Nakedi Kehilwe C KC   Garnett Shaun S   Nel Andrew J M AJ   Soares Nelson C NC   Blackburn Jonathan M JM  

Scientific reports 20170306


In the last 40 years only one new antitubercular drug has been approved, whilst resistance to current drugs, including rifampicin, is spreading. Here, we used the model organism Mycobacterium smegmatis to study mechanisms of phenotypic mycobacterial resistance, employing quantitative mass spectrometry-based proteomics to investigate the temporal effects of sub-lethal concentrations of rifampicin on the mycobacterial proteome at time-points corresponding to early response, onset of bacteriostasis  ...[more]

Similar Datasets

2017-03-15 | PXD004197 | Pride
2011-01-06 | E-GEOD-26474 | biostudies-arrayexpress
2015-01-01 | E-MTAB-2929 | biostudies-arrayexpress
2011-07-01 | E-GEOD-30236 | biostudies-arrayexpress
2012-03-08 | E-GEOD-36345 | biostudies-arrayexpress
2010-08-20 | GSE19774 | GEO
2022-04-21 | PXD025604 | JPOST Repository
2022-08-30 | MSV000090235 | MassIVE
2018-02-18 | GSE104978 | GEO
2013-11-05 | GSE34622 | GEO